Ginkgo Bioworks Holdings (DNA) Long-Term Investments (2021 - 2023)

Ginkgo Bioworks Holdings has reported Long-Term Investments for 3 years, with the latest figure at $1.1 million in Q3 2023.

• For the quarter ending Q3 2023, Long-Term Investments fell 98.84% year-over-year to $1.1 million; the trailing twelve-month figure through Sep 2023 stood at $1.1 million (down 98.84% YoY), and the FY2022 full-year result was $1.5 million, down 88.31% from the prior year.
• Long-Term Investments for Q3 2023 stood at $1.1 million, down from $119.9 million in the prior quarter.
• The five-year high for Long-Term Investments was $1.7 billion in Q2 2021, with the low at $1.1 million in Q3 2023.
• Historically, Long-Term Investments has averaged $209.6 million across 3 years, with a median of $96.3 million in 2022.
• Annual changes were most pronounced in 2022 — Long-Term Investments slumped 99.6% — and 2023, when it jumped 1634.8%.
• Ginkgo Bioworks Holdings' Long-Term Investments stood at $13.2 million in 2021, then slumped by 88.31% to $1.5 million in 2022, then slipped by 27.41% to $1.1 million in 2023.
• The last three Long-Term Investments figures came in at $1.1 million (Q3 2023), $119.9 million (Q2 2023), and $121.8 million (Q1 2023), per Business Quant data.